These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 17853920

  • 21. Arming Oncolytic Adenoviruses: Effect of Insertion Site and Splice Acceptor on Transgene Expression and Viral Fitness.
    Farrera-Sal M, de Sostoa J, Nuñez-Manchón E, Moreno R, Fillat C, Bazan-Peregrino M, Alemany R.
    Int J Mol Sci; 2020 Jul 21; 21(14):. PubMed ID: 32708234
    [Abstract] [Full Text] [Related]

  • 22. Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII.
    Andrews JL, Kadan MJ, Gorziglia MI, Kaleko M, Connelly S.
    Mol Ther; 2001 Mar 21; 3(3):329-36. PubMed ID: 11273775
    [Abstract] [Full Text] [Related]

  • 23. Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo.
    Schowalter DB, Tubb JC, Liu M, Wilson CB, Kay MA.
    Gene Ther; 1997 Apr 21; 4(4):351-60. PubMed ID: 9176522
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A potent replicative delta-24 adenoviral vector driven by the promoter of human papillomavirus 16 that is highly selective for associated neoplasms.
    Delgado-Enciso I, Cervantes-García D, Martínez-Dávila IA, Ortiz-López R, Alemany-Bonastre R, Silva-Platas CI, Lugo-Trampe A, Barrera-Saldaña HA, Galván-Salazar HR, Coronel-Tene CG, Sánchez-Santillán CF, Rojas-Martínez A.
    J Gene Med; 2007 Oct 21; 9(10):852-61. PubMed ID: 17729237
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Quantitative analysis of transgene protein, mRNA, and vector DNA following injection of an adenoviral vector harboring glial cell line-derived neurotrophic factor into the primate caudate nucleus.
    Kozlowski DA, Bremer E, Redmond DE, George D, Larson B, Bohn MC.
    Mol Ther; 2001 Feb 21; 3(2):256-61. PubMed ID: 11237683
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Tumor-specific intravenous gene delivery using oncolytic adenoviruses.
    Zhan J, Gao Y, Wang W, Shen A, Aspelund A, Young M, Laquerre S, Post L, Shen Y.
    Cancer Gene Ther; 2005 Jan 21; 12(1):19-25. PubMed ID: 15514685
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Development of a recombinant adenovirus vector production system free of replication-competent adenovirus by utilizing a packaging size limit of the viral genome.
    Suzuki T, Sasaki T, Yano K, Sakurai F, Kawabata K, Kondoh M, Hayakawa T, Yagi K, Mizuguchi H.
    Virus Res; 2011 Jun 21; 158(1-2):154-60. PubMed ID: 21470569
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Selectivity and efficiency of late transgene expression by transcriptionally targeted oncolytic adenoviruses are dependent on the transgene insertion strategy.
    Quirin C, Rohmer S, Fernández-Ulibarri I, Behr M, Hesse A, Engelhardt S, Erbs P, Enk AH, Nettelbeck DM.
    Hum Gene Ther; 2011 Apr 21; 22(4):389-404. PubMed ID: 20939692
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells.
    Chen L, Chen D, Gong M, Na M, Li L, Wu H, Jiang L, Qian Y, Fang G, Xue X.
    Cancer Lett; 2009 Nov 01; 284(2):141-8. PubMed ID: 19447545
    [Abstract] [Full Text] [Related]

  • 40. Oncolytic adenoviral vector carrying the cytosine deaminase gene for melanoma gene therapy.
    Liu Y, Deisseroth A.
    Cancer Gene Ther; 2006 Sep 01; 13(9):845-55. PubMed ID: 16710344
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.